AtriCure (ATRC) Insider Trading & Ownership $35.60 -0.58 (-1.60%) Closing price 04:00 PM EasternExtended Trading$35.59 -0.01 (-0.03%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AtriCure (NASDAQ:ATRC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$971.76K Get ATRC Insider Trade Alerts Want to know when executives and insiders are buying or selling AtriCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ATRC Insider Buying and Selling by Quarter AtriCure Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/12/2025Justin J NozneskyInsiderSell3,000$36.30$108,900.00 8/22/2025Sven WehrweinDirectorSell5,000$37.00$185,000.00 8/19/2025Sven WehrweinDirectorSell5,000$36.00$180,000.00 8/6/2025Regina E GrovesDirectorSell2,452$36.82$90,282.64 8/5/2025Vinayak DoraiswamyInsiderSell2,500$36.58$91,450.00 5/28/2025Vinayak DoraiswamyInsiderSell2,500$33.44$83,600.00 5/6/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$29.97$1,001 - $15,0003/5/2025Karen PrangeDirectorSell6,100$38.12$232,532.00 (Data available from 1/1/2013 forward) ATRC Insider Trading Activity - Frequently Asked Questions Who is on AtriCure's Insider Roster? The list of insiders at AtriCure includes Justin J Noznesky, Karen Prange, Karl S Dahlquist, Maggie Yuen, Regina E Groves, Salvatore Privitera, Sven Wehrwein, and Vinayak Doraiswamy. Learn more on insiders at ATRC. What percentage of AtriCure stock is owned by insiders? 3.50% of AtriCure stock is owned by insiders. Learn more on ATRC's insider holdings. Which AtriCure insiders have been buying company stock? The following insider purchased ATRC shares in the last 24 months: Salvatore Privitera ($111,250.00). How much insider buying is happening at AtriCure? Insiders have purchased a total of 5,000 ATRC shares in the last 24 months for a total of $111,250.00 bought. Which AtriCure insiders have been selling company stock? The following insiders have sold ATRC shares in the last 24 months: Justin J Noznesky ($245,700.00), Karen Prange ($232,532.00), Karl S Dahlquist ($411,100.40), Maggie Yuen ($84,245.00), Regina E Groves ($90,282.64), Sven Wehrwein ($365,000.00), and Vinayak Doraiswamy ($175,050.00). How much insider selling is happening at AtriCure? Insiders have sold a total of 45,916 AtriCure shares in the last 24 months for a total of $1,603,910.04 sold. Which members of congress are trading AtriCure? Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of AtriCure in the last year totaling $8,000. AtriCure Key ExecutivesMr. Michael H. Carrel (Age 53)CEO, President & Director Compensation: $2.01MMs. Angela L. Wirick CPA (Age 46)Chief Financial Officer Compensation: $841.54kMr. Douglas J. Seith (Age 58)Chief Operating Officer Compensation: $1.2MMr. Salvatore Privitera J.D. (Age 57)Chief Technical Officer Compensation: $758.8kMr. Karl S. Dahlquist CCEP (Age 53)J.D., Chief Legal Officer Compensation: $762.39kDr. Vinayak Doraiswamy Ph.D. (Age 52)Chief Scientific Officer Compensation: $777.66kValerie Storch-WillhausVice President of Corporate Marketing & CommunicationsMr. Justin J. Noznesky (Age 46)Chief Marketing & Strategy Officer Compensation: $644.73k1 recent tradesMs. Deborah Yount (Age 58)Chief Human Resources Officer Compensation: $498.36k More Insider Trading Tools from MarketBeat Related Companies TFX Insider Trading ITGR Insider Trading ATEC Insider Trading IART Insider Trading OFIX Insider Trading ANGO Insider Trading SRDX Insider Trading ARAY Insider Trading RMTI Insider Trading ABT Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NASDAQ:ATRC) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
